FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine. Container for replenished homogenous gamma-radiation source based on aqueous solution of sodium 99mTc-pertechnetate characterized in that the container is made in the form of a parallelepiped of acrylic plastic with size of 51×51×4 cm and volume of 5,000 cm3. On upper edge of reservoir there are two round holes with thread ∅ 8.8 mm for metal bolts with silicone gaskets. On rear surface of container there are symmetrically arranged four ledges at distance of 4.5 cm from side faces with size of 5×5 cm for installation of container into "holder for homogeneous source". Method for contouring a patient's body for indirect planar whole body lymphoscintigraphy involves administering to a patient a preparation based on 99mTc-labeled colloidal nanoparticles with activity of up to 110 MBq, and 30 minutes after the introduction, the gamma-camera is used for indirect planar lymphoscintigraphy in the "whole body" mode. Two-detector rotary gamma-ray monitor is used to specify the protocol of indirect planar lymphoscintigraphy. Signal is recorded only by upper detector. Lower detector is switched off and a holder with solution of sodium 99mTc-pertechnetate, uniformly distributed in 5 l of distilled water, is placed on it. After the examination is completed, the obtained images are evaluated, wherein the patient's body is defined as a homogeneous section which does not transmit a signal to the detector, and the injection site and the lymph drainage path - in the form of high-signal centers and zones, wherein the sentinel lymph node is visualized on the lymphoscintigram as a bright RPA hyper fixation center in the projection of the potential lymphatic drain zone.
EFFECT: use of this group of inventions is cost-effective, easy to implement, has high throughput capacity, since it does not require long time for preparation and postprocessor processing, and enables to obtain data from the entire region of interest.
2 cl, 12 dwg, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR RADIONUCLIDE DIAGNOSTICS OF LUNG CANCER | 2020 |
|
RU2751103C1 |
METHOD FOR ASSESSING THE EFFECTIVENESS OF CHEMOTHERAPY FOR MALIGNANT LYMPHOMAS | 2019 |
|
RU2700105C1 |
METHOD FOR RADIONUCLIDE DIAGNOSING OF CEREBRAL TUMORS | 2017 |
|
RU2692451C2 |
METHOD FOR RADIONUCLIDE DIAGNOSTICS OF MALIGNANT LYMPHOMAS | 2018 |
|
RU2706602C1 |
COLON CANCER DIAGNOSIS METHOD | 2021 |
|
RU2755010C1 |
METHOD FOR RADIONUCLIDE DIAGNOSING OPERABLE BREAST CANCER WITH OVEREXPRESSION OF HER2/NEU | 2019 |
|
RU2702294C1 |
METHOD FOR TARGETED BRACHYTHERAPY OF PROSTATE CANCER UNDER HYBRID PSMA-RECEPTOR SCINTIGRAPHY NAVIGATION | 2022 |
|
RU2788859C2 |
RADIONUCLIDE DIAGNOSTIC TECHNIQUE FOR BREAST CANCER WITH Her2/neu HYPEREXPRESSION | 2019 |
|
RU2720801C1 |
METHOD OF RADIONUCLIDAL DIAGNOSTICS OF LARYNGEAL AND PHARYNGOPHARYNGEAL CANCER | 2017 |
|
RU2679298C1 |
METHOD OF RADIONUCLIDAL DIAGNOSTICS OF BREAST CANCER | 2017 |
|
RU2682880C1 |
Authors
Dates
2020-12-07—Published
2020-06-05—Filed